Fisetin and Skin Aging: What the Research Says About Senescent Cell Clearance in Dermal Tissue
Fisetin is under study as a senolytic compound that may clear senescent cells in the dermis. Here is what the current evidence actually shows.
Fisetin is under study as a senolytic compound that may clear senescent cells in the dermis. Here is what the current evidence actually shows.
Fisetin is studied as a senolytic targeting ‘zombie’ cells. Here’s an honest look at what mouse research shows—and what remains unknown in humans.
Fisetin is studied as a senolytic and senomorphic agent that may reduce SASP-driven inflammation. Here is what the current preclinical evidence actually shows.
A close look at the landmark 2018 EBioMedicine study on fisetin, senescent cells, and lifespan extension in mice—what it found and what it means for humans.
Fisetin is a plant flavonoid studied for metabolic effects including insulin resistance and diabetic complications. An honest look at the early evidence.
A plain-language look at AFFIRM-LITE, Mayo Clinic’s pilot trial testing fisetin as a senolytic in older adults with physical dysfunction and frailty.
Can the senolytic flavonoid fisetin shift your biological age? A careful look at DNA methylation clock research, honest findings, and real limitations.
Fisetin is a naturally occurring flavonol found in a surprisingly wide range of everyday fruits and vegetables, though it tends
Explore the evidence on fisetin’s cognitive benefits, including memory, learning, and neuroprotection. What animal studies show — and what remains unproven in h
An evidence-based look at fisetin’s proposed senolytic mechanisms in vascular aging, arterial function, and endothelial health — with honest caveats on what rem
A science-honest look at fisetin’s apoptosis mechanisms across cancer cell lines, the molecular targets studied, and why preclinical data has clear limits.
Fisetin, a plant flavonoid, has shown osteoclast-inhibiting effects in preclinical models via NF-κB and MKP-1 pathways. Here is what the evidence says.